David Kaslow, FDA's incoming director of CBER's Office of Vaccines Research and Review
FDA hires new vaccine director, a year after two senior leaders quit in protest
After almost exactly a year since the FDA’s top two vaccine leaders left in protest over boosters-for-all, the FDA has now named former Merck VP …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
